Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow cytometry: A EuroFlow study. - Verbeek MWC; Reiterová M; Laqua A; Rodríguez BS; Sedek L; Buracchi C; Buysse M; Oliveira E; Engelmann R; Desterro J; De Jong AX; Boettcher S; et al. (HemaSphere, 2025)